Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Using a confined culture system (CCS), the team grew small intestine, colon, and...
David Baker’s latest company is making medicines for a huge protein family once ...
Preclinical studies revealed new insights into PI5P4K enzymes that help move cho...
The company’s IPO filing came a day after Parabilis inked an up-to-$2.3 billion-...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and ...
In this episode of GEN's Touching Base, editors celebrate the 50th episode. They...
AI has fundamentally transformed how we understand the world. Large language mod...
If you’ve ever stared at a USMLE Step 1 question and thought, “I know I’ve seen ...
Venus Remedies, among the world’s ten largest fixed-dosage injectable manufactu...
Platinum Industries, an innovation-driven specialty chemicals company announced...
Central Drugs Standard Control Organisation (CDSCO) has issued a public notice ...
Blog Series — Part 2 of 3 The real freedoms, the real trade-offs, and what every...
Due to ‘fundamental weaknesses’ in its governance, risk management and control f...
This Sunday, a group of 42 athletes will gather in Las Vegas to compete in a som...
First announced last month, the move aims to advance Gilead’s oncology portfolio...
The collaboration aims to accelerate hit identification for these companies thro...
